Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to $98000.0.

  • Sight Sciences' Change in Receivables rose 10136.85% to $98000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year increase of 2673.68%. This contributed to the annual value of -$3.5 million for FY2024, which is 43630.86% down from last year.
  • Latest data reveals that Sight Sciences reported Change in Receivables of $98000.0 as of Q3 2025, which was up 10136.85% from $215000.0 recorded in Q2 2025.
  • Sight Sciences' 5-year Change in Receivables high stood at $4.3 million for Q2 2024, and its period low was -$7.2 million during Q3 2024.
  • Over the past 5 years, Sight Sciences' median Change in Receivables value was $690000.0 (recorded in 2022), while the average stood at $279736.8.
  • Per our database at Business Quant, Sight Sciences' Change in Receivables surged by 1980000.0% in 2022 and then crashed by 78626.24% in 2024.
  • Over the past 5 years, Sight Sciences' Change in Receivables (Quarter) stood at -$13000.0 in 2021, then surged by 19800.0% to $2.6 million in 2022, then tumbled by 211.21% to -$2.8 million in 2023, then rose by 25.63% to -$2.1 million in 2024, then skyrocketed by 104.63% to $98000.0 in 2025.
  • Its last three reported values are $98000.0 in Q3 2025, $215000.0 for Q2 2025, and -$1.3 million during Q1 2025.